107 related articles for article (PubMed ID: 10479276)
1. Conceptually new sulfone analogues of the hormone 1alpha, 25-dihydroxyvitamin D(3): synthesis and preliminary biological evaluation.
Posner GH; Wang Q; Han G; Lee JK; Crawford K; Zand S; Brem H; Peleg S; Dolan P; Kensler TW
J Med Chem; 1999 Sep; 42(18):3425-35. PubMed ID: 10479276
[TBL] [Abstract][Full Text] [Related]
2. Low-calcemic, highly antiproliferative, 1-difluoromethyl hybrid analogs of the natural hormone 1alpha,25-dihydroxyvitamin D3: design, synthesis, and preliminary biological evaluation.
Peleg S; Petersen KS; Suh BC; Dolan P; Agoston ES; Kensler TW; Posner GH
J Med Chem; 2006 Dec; 49(25):7513-7. PubMed ID: 17149880
[TBL] [Abstract][Full Text] [Related]
3. The biological activity of nonsteroidal vitamin D hormone analogs lacking both the C- and D-rings.
Verstuyf A; Verlinden L; Van Baelen H; Sabbe K; D'Hallewyn C; De Clercq P; Vandewalle M; Bouillon R
J Bone Miner Res; 1998 Apr; 13(4):549-58. PubMed ID: 9556055
[TBL] [Abstract][Full Text] [Related]
4. Conceptually new 20-epi-22-oxa sulfone analogues of the hormone 1alpha,25-dihydroxyvitamin D(3): synthesis and biological evaluation.
Posner GH; Crawford K; Siu-Caldera ML; Reddy GS; Sarabia SF; Feldman D; van Etten E; Mathieu C; Gennaro L; Vouros P; Peleg S; Dolan PM; Kensler TW
J Med Chem; 2000 Sep; 43(19):3581-6. PubMed ID: 11000014
[TBL] [Abstract][Full Text] [Related]
5. Noncalcemic, antiproliferative, transcriptionally active, 24-fluorinated hybrid analogues of the hormone 1alpha, 25-dihydroxyvitamin D3. Synthesis and preliminary biological evaluation.
Posner GH; Lee JK; Wang Q; Peleg S; Burke M; Brem H; Dolan P; Kensler TW
J Med Chem; 1998 Jul; 41(16):3008-14. PubMed ID: 9685240
[TBL] [Abstract][Full Text] [Related]
6. Natural metabolites of 1alpha,25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor.
Harant H; Spinner D; Reddy GS; Lindley IJ
J Cell Biochem; 2000 Apr; 78(1):112-20. PubMed ID: 10797570
[TBL] [Abstract][Full Text] [Related]
7. 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3 and 1alpha,25-dihydroxy-16-ene-23-yne-20-epi-vitamin D3: analogs of 1alpha,25-dihydroxyvitamin D3 that resist metabolism through the C-24 oxidation pathway are metabolized through the C-3 epimerization pathway.
Reddy GS; Rao DS; Siu-Caldera ML; Astecker N; Weiskopf A; Vouros P; Sasso GJ; Manchand PS; Uskokovic MR
Arch Biochem Biophys; 2000 Nov; 383(2):197-205. PubMed ID: 11185554
[TBL] [Abstract][Full Text] [Related]
8. New 1alpha,25-dihydroxy-19-norvitamin D3 compounds of high biological activity: synthesis and biological evaluation of 2-hydroxymethyl, 2-methyl, and 2-methylene analogues.
Sicinski RR; Prahl JM; Smith CM; DeLuca HF
J Med Chem; 1998 Nov; 41(23):4662-74. PubMed ID: 9804706
[TBL] [Abstract][Full Text] [Related]
9. A-ring hydroxymethyl 19-nor analogs of the natural hormone 1alpha,25-dihydroxyvitamin D(3): synthesis and preliminary biological evaluation.
Hatcher MA; Peleg S; Dolan P; Kensler TW; Sarjeant A; Posner GH
Bioorg Med Chem; 2005 Jun; 13(12):3964-76. PubMed ID: 15878279
[TBL] [Abstract][Full Text] [Related]
10. A non-calcemic sulfone version of the vitamin D(3) analogue seocalcitol (EB 1089): chemical synthesis, biological evaluation and potency enhancement of the anticancer drug adriamycin.
Posner GH; Crawford KR; Peleg S; Welsh JE; Romu S; Gewirtz DA; Gupta MS; Dolan P; Kensler TW
Bioorg Med Chem; 2001 Sep; 9(9):2365-71. PubMed ID: 11553477
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, biological activity, and conformational analysis of four seco-D-15,19-bisnor-1alpha,25-dihydroxyvitamin D analogues, diastereomeric at C17 and C20.
Zhou X; Zhu GD; Van Haver D; Vandewalle M; De Clercq PJ; Verstuyf A; Bouillon R
J Med Chem; 1999 Sep; 42(18):3539-56. PubMed ID: 10479287
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological activities of new 1alpha,25-dihydroxy-19-norvitamin D3 analogs with modifications in both the A-ring and the side chain.
Shimizu M; Miyamoto Y; Kobayashi E; Shimazaki M; Yamamoto K; Reischl W; Yamada S
Bioorg Med Chem; 2006 Jun; 14(12):4277-94. PubMed ID: 16503143
[TBL] [Abstract][Full Text] [Related]
13. The first locked side-chain analogues of calcitriol (1alpha,25-dihydroxyvitamin D3) induce vitamin D receptor transcriptional activity.
Pérez-García X; Rumbo A; Larriba MJ; Ordóñez P; Muñoz A; Mouriño A
Org Lett; 2003 Oct; 5(22):4033-6. PubMed ID: 14572242
[TBL] [Abstract][Full Text] [Related]
14. Characterization of five 19-nor-analogs of 1alpha,25(OH)2-Vitamin D3 with 20-cyclopropyl-modified side-chains: implications for ligand binding and calcemic properties.
Olivera CJ; Bula CM; Bishop JE; Adorini L; Manchand P; Uskokovic MR; Norman AW
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):99-106. PubMed ID: 15225754
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of 1α,25-dihydroxyvitamin D₃ analogues with a long side chain at C12 and short C17 side chains.
Carballa DM; Seoane S; Zacconi F; Pérez X; Rumbo A; Alvarez-Díaz S; Larriba MJ; Pérez-Fernández R; Muñoz A; Maestro M; Mouriño A; Torneiro M
J Med Chem; 2012 Oct; 55(20):8642-56. PubMed ID: 22989379
[TBL] [Abstract][Full Text] [Related]
16. Analogs of 1alpha,25-dihydroxyvitamin D3 with high potency in induction of osteoclastogenesis and prevention of dendritic cell differentiation: synthesis and biological evaluation of 2-substituted 19-norvitamin D analogs.
Shimazaki M; Miyamoto Y; Yamamoto K; Yamada S; Takami M; Shinki T; Udagawa N; Shimizu M
Bioorg Med Chem; 2006 Jul; 14(13):4645-56. PubMed ID: 16513359
[TBL] [Abstract][Full Text] [Related]
17. Antiproliferative, low-calcemic, fluorinated sulfone analogs of 1alpha,25-dihydroxyvitamin D3: chemical synthesis and biological evaluation.
Usera AR; Dolan PM; Kensler TW; Posner GH
Bioorg Med Chem; 2007 Aug; 15(16):5509-18. PubMed ID: 17560112
[TBL] [Abstract][Full Text] [Related]
18. New 2-alkylidene 1alpha,25-dihydroxy-19-norvitamin D3 analogues of high intestinal activity: synthesis and biological evaluation of 2-(3'-alkoxypropylidene) and 2-(3'-hydroxypropylidene) derivatives.
Glebocka A; Sicinski RR; Plum LA; Clagett-Dame M; DeLuca HF
J Med Chem; 2006 May; 49(10):2909-20. PubMed ID: 16686534
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationships of 19-norvitamin D analogs having a fluoroethylidene group at the C-2 position.
Kobayashi E; Shimazaki M; Miyamoto Y; Masuno H; Yamamoto K; DeLuca HF; Yamada S; Shimizu M
Bioorg Med Chem; 2007 Feb; 15(3):1475-82. PubMed ID: 17110116
[TBL] [Abstract][Full Text] [Related]
20. Novel 1alpha,25-dihydroxyvitamin D3 analogues with the side chain at C12.
González-Avión XC; Mouriño A; Rochel N; Moras D
J Med Chem; 2006 Mar; 49(5):1509-16. PubMed ID: 16509569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
